Cart
sales@molnova.com
CAY10465
CAS No. 688348-33-6
CAY10465( —— )
Catalog No. M19000 CAS No. 688348-33-6
CAY 10465 is a selective and high-affinity AhR agonist, with a Ki of 0.2 nM, and shows no effect on estrogen receptor (Ki >100000 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 40 | In Stock |
|
| 5MG | 63 | In Stock |
|
| 10MG | 101 | In Stock |
|
| 25MG | 215 | In Stock |
|
| 50MG | 408 | In Stock |
|
| 100MG | 618 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCAY10465
-
NoteResearch use only, not for human use.
-
Brief DescriptionCAY 10465 is a selective and high-affinity AhR agonist, with a Ki of 0.2 nM, and shows no effect on estrogen receptor (Ki >100000 nM).
-
DescriptionCAY 10465 is a selective and high-affinity AhR agonist, with a Ki of 0.2 nM, and shows no effect on estrogen receptor (Ki >100000 nM).
-
In VitroCAY 10465 (Compound 4i) is a selective and high-affinity AhR receptor agonist, with a Ki of 0.2 nM, and shows no effect on estrogen receptor (Ki >100000 nM). CAY 10465 (0.01 nM-100 μM) reduces apolipoprotein A-I (apo A-I) levels in HepG2 cells, and inhibits the synthesis of the protein.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number688348-33-6
-
Formula Weight317.1
-
Molecular FormulaC15H9Cl2F3
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 100 mg/mL; 315.33 mM
-
SMILESFC(F)(F)c1ccc(cc1)\C=C\c1cc(Cl)cc(Cl)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Isomucronulatol 7-O-...
Isomucronulatol 7-O-beta-glucoside is a natural product.
-
1,3-diethyl 2-(3-met...
1,3-diethyl 2-(3-methoxyphenyl)propanedioate is a compound used as a molecular building block.
-
Lasmiditan
Lasmiditan, also known as COL-144 and LY573144, is a novel, centrally acting, highly selective 5-HT(1F) receptor agonist (K1=2.21 μM) without vasoconstrictor activity that seemed effective when given as an intravenous infusion in a proof-of-concept migraine study.
